60483_BioElectronis.jpg
Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation
03. Dezember 2024 08:15 ET | BioElectronics Corporation
FREDERICK, Md., Dec. 03, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL, a developer of medical technology products, today announces that Sree Koneru, PhD,...
60483_BioElectronis.jpg
BioElectronics Corporation's Chairman Updates Investors
16. Oktober 2024 08:45 ET | BioElectronics Corporation
Outlines Sales Activities, Clinical Trials, and a Potential Legal Action Against MundiPharma FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/...
60483_BioElectronis.jpg
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
25. März 2024 08:45 ET | BioElectronics Corporation
96% of the Dogs Treated With the Active Model 088 Device Showed Marked Improvement FREDERICK, MD, March 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation...
60483_BioElectronis.jpg
BioElectronics Corporation Announces the Publication of Pilot Study Results
23. Februar 2024 08:30 ET | BioElectronics Corporation
Beneficial Treatment Effect for Phantom and Residual Limb Pain Identified FREDERICK, MD, Feb. 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/...
60483_BioElectronis.jpg
BioElectronics Chairman Updates Investors
15. Februar 2024 09:00 ET | BioElectronics Corporation
Discusses Clinical Trial Progress and Potential Legal Action Against MundiPharma FREDERICK, MD, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation...
60483_BioElectronis.jpg
End of Year Message From the Chairman of the Board of BioElectronics
22. Dezember 2023 15:55 ET | BioElectronics Corporation
FREDERICK, MD, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corp. (OTC: BIEL) is pleased to provide this end of year message to investors, customers, suppliers and other...
60483_BioElectronis.jpg
BioElectronics’ Chairman Discusses Recent Clinical Research Findings
22. Juli 2022 06:00 ET | BioElectronics Corporation
Company Receives Initial Purchase Order From Stada MENA FREDERICK, MD, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a...
60483_BioElectronis.jpg
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
06. April 2022 06:00 ET | BioElectronics Corporation
FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that...
60483_BioElectronis.jpg
BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico
30. März 2022 06:00 ET | BioElectronics Corporation
FREDERICK, MD, March 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has...
60483_BioElectronis.jpg
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
28. Februar 2022 07:00 ET | BioElectronics Corporation
FREDERICK, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard...